Home > Journals > Minerva Endocrinology > Past Issues > Minerva Endocrinology 2021 June;46(2) > Minerva Endocrinology 2021 June;46(2):233-4

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

LETTERS TO THE EDITOR   Freefree

Minerva Endocrinology 2021 June;46(2):233-4

DOI: 10.23736/S2724-6507.21.03441-6

Copyright © 2021 EDIZIONI MINERVA MEDICA

language: English

Patients diagnosed with low-risk thyroid cancer during COVID-19 pandemic: what did they ask surgeons?

Pierpaolo TRIMBOLI 1, 2 , Arnoldo PICCARDO 3, Alessandra COSSA 4, Maurilio DEANDREA 5, Anda M. NACIU 6, Gaia TABACCO 6, Ugo CATRAMBONE 7, Giovanni CANALE 8, Lorenzo DANIELE 9, Stefano VALABREGA 4, Andrea PALERMO 6, Carlo BELLOTTI 4

1 Clinic for Endocrinology and Diabetology, Lugano Regional Hospital, Lugano, Switzerland; 2 Faculty of Biomedical Sciences, Università della Svizzera Italiana (USI), Lugano, Switzerland; 3 Department of Nuclear Medicine, E.O. Ospedali Galliera, Genoa, Italy; 4 Department of Medical and Surgical Sciences, S. Andrea Hospital, Sapienza University, Rome, Italy; 5 Department of Endocrinology, Diabetes and Metabolism, Center for Thyroid Diseases, Mauriziano Hospital, Turin, Italy; 6 Unit of Metabolic Disease, Campus Bio-Medico University, Rome, Italy; 7 Department of Surgery, E.O. Ospedali Galliera, Genoa, Italy; 8 Division of Otolaryngology, Mauriziano Hospital, Turin, Italy; 9 Unit of Pathology, Mauriziano Hospital, Turin, Italy



top of page